Literature DB >> 26401941

Differential Effects of Meal Challenges on Cognition, Metabolism, and Biomarkers for Apolipoprotein E ɛ4 Carriers and Adults with Mild Cognitive Impairment.

Angela J Hanson1, Jennifer L Bayer2, Laura D Baker3, Brenna Cholerton1, Brian VanFossen4, Emily Trittschuh4, Robert A Rissman5, Michael C Donohue5, Setareh H Moghadam5, Stephen R Plymate, Suzanne Craft3.   

Abstract

BACKGROUND: High intake of saturated fat (SF) and glycemic index (GI) foods is a risk factor for sporadic Alzheimer's disease. Meal challenges may elucidate mechanisms that contribute to this risk, enabling development of targeted interventions.
OBJECTIVE: To assess cognitive and metabolic changes after a meal high in SF and GI calories (HIGH) versus a meal low in these macronutrients (LOW) in older adults with and without cognitive impairment, and with and without the apolipoprotein E4 risk factor.
METHODS: 46 adults with either cognitive impairment (CI) or normal cognition (NC) ingested a LOW (25% total fat, 7% SF, GI <55) and a HIGH meal (50% total fat, 25% SF, GI >70) in a blinded random fashion. Participants then underwent cognitive testing and blood sampling for metabolic and Alzheimer's disease biomarkers. Data were analyzed using repeated measures ANOVA and Spearman correlations.
RESULTS: E4-adults with NC demonstrated lower delayed memory scores after the HIGH compared to the LOW meal, whereas normal E4+ and CI E4- groups had higher scores after the HIGH meal (ANOVA p = 0.03). These findings were associated with meal-induced changes in glucose (p = 0.05), insulin (p = 0.004), triglycerides (p <  0.01), and plasma Aβ42 (p = 0.05).
CONCLUSIONS: These preliminary data suggest that cognitive performance of adults without CI may worsen following high SF and sugar meals, whereas adults with CI or those at risk for CI due to E4 status may benefit acutely from such meals. Furthermore, plasma Aβ was affected by meal type, suggesting a relationship between metabolic response and amyloid regulation.

Entities:  

Keywords:  APOE genotype; Alzheimer’s disease; glycemic index; insulin; plasma amyloid; saturated fat; triglycerides

Mesh:

Substances:

Year:  2015        PMID: 26401941     DOI: 10.3233/JAD-150273

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  18 in total

Review 1.  Insulin resistance, dyslipidemia, and apolipoprotein E interactions as mechanisms in cognitive impairment and Alzheimer's disease.

Authors:  Therese S Salameh; Elizabeth M Rhea; William A Banks; Angela J Hanson
Journal:  Exp Biol Med (Maywood)       Date:  2016-07-28

2.  APOE Genotype Influences Postprandial Blood Pressure after High Fat Feeding in Older Adults.

Authors:  K C Stewart; D Subramanian; U J Neal; A J Hanson
Journal:  J Nutr Health Aging       Date:  2019       Impact factor: 4.075

Review 3.  Blood-Brain Barriers in Obesity.

Authors:  Elizabeth M Rhea; Therese S Salameh; Aric F Logsdon; Angela J Hanson; Michelle A Erickson; William A Banks
Journal:  AAPS J       Date:  2017-04-10       Impact factor: 4.009

4.  A Scoping Review of Dietary Factors Conferring Risk or Protection for Cognitive Decline in APOE ε4 Carriers.

Authors:  G M Fote; N R Geller; A M Reyes-Ortiz; L M Thompson; J S Steffan; J D Grill
Journal:  J Nutr Health Aging       Date:  2021       Impact factor: 4.075

5.  Dietary Glycemic Load and Plasma Amyloid-β Biomarkers of Alzheimer's Disease.

Authors:  Mélissa Gentreau; Michel Raymond; Cécilia Samieri; Virginie Chuy; Catherine Féart; Claire Berticat; Sylvaine Artero
Journal:  Nutrients       Date:  2022-06-15       Impact factor: 6.706

6.  Dietary saturated fat and monounsaturated fat have reversible effects on brain function and the secretion of pro-inflammatory cytokines in young women.

Authors:  Julie A Dumas; Janice Y Bunn; Joshua Nickerson; Karen I Crain; David B Ebenstein; Emily K Tarleton; Jenna Makarewicz; Matthew E Poynter; Craig Lawrence Kien
Journal:  Metabolism       Date:  2016-08-09       Impact factor: 8.694

Review 7.  ApoE and cerebral insulin: Trafficking, receptors, and resistance.

Authors:  Elizabeth M Rhea; Jacob Raber; William A Banks
Journal:  Neurobiol Dis       Date:  2020-01-21       Impact factor: 5.996

Review 8.  Clinical Application of APOE in Alzheimer's Prevention: A Precision Medicine Approach.

Authors:  C L Berkowitz; L Mosconi; A Rahman; O Scheyer; H Hristov; R S Isaacson
Journal:  J Prev Alzheimers Dis       Date:  2018

Review 9.  Oxidative Stress, Synaptic Dysfunction, and Alzheimer's Disease.

Authors:  Eric Tönnies; Eugenia Trushina
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

10.  Cerebrospinal fluid lipidomics: effects of an intravenous triglyceride infusion and apoE status.

Authors:  Angela J Hanson; William A Banks; Lisa F Bettcher; Robert Pepin; Daniel Raftery; Suzanne Craft
Journal:  Metabolomics       Date:  2019-12-12       Impact factor: 4.290

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.